Lupin receives European Commission approval for biosimilar ranibizumab RanluspecTM
Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.